Tatva Chintan Pharma Chem
BSE 543321 · ISIN INE0GK401011
9 stories, newest first.
- Tatva Chintan Pharma shares fell about 10% to their lowest level in 23 sessions
- Tatva Chintan Pharma rose on good numbers and is holding up even in a weak market; a guest said the trend is positive and gave a hold call
- Updated Investor Presentation: H1FY27 RoE revised to 6.3%, Debt to EBITDA to 1.16
- Tatva Chintan Q2FY27 revenue up 76% YoY to ₹2,173 Mn, PAT up 116%
- Earnings call scheduled for 19 October 2026 cancelled, company cites unforeseen circumstances
- Consolidated results for the quarter ended 30.09.2026 (Unaudited)
- Tatva Chintan schedules one-to-one virtual meet with Motilal Oswal on 26 October 2026
- Tatva Chintan Pharma Chem to hold Q2FY27 earnings call on 19 October 2026
- Board meeting on 19 October 2026 to consider September quarter results
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.